心血管ペーシングおよび植込み型除細動器(ICD)リード:医療機器パイプライン分析

◆英語タイトル:Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Medical Devices Pipeline Assessment, 2019
◆商品コード:GDT20FB0133
◆発行会社(リサーチ会社):GlobalData
◆発行日:2019年12月
◆ページ数:101
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥262,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD5,000 ⇒換算¥525,000見積依頼/購入/質問フォーム
Enterprisewide Price(複数事業所内共有可)USD7,500 ⇒換算¥787,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads – Medical Devices Pipeline Assessment, 2019
Summary

GlobalData’s Medical Devices sector report, “Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads – Medical Devices Pipeline Assessment, 2019″ provides an overview of Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

Table of Contents
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads Overview 6
3 Products under Development 7
3.1 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads – Pipeline Products by Stage of Development 7
3.2 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads – Pipeline Products by Territory 8
3.3 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads – Pipeline Products by Regulatory Path 9
3.4 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads – Pipeline Products by Estimated Approval Date 10
3.5 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads – Ongoing Clinical Trials 11
4 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads – Pipeline Products under Development by Companies 12
4.1 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads Companies – Pipeline Products by Stage of Development 12
4.2 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads – Pipeline Products by Stage of Development 13
5 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads Companies and Product Overview 14
5.1 Boston Scientific Corp Company Overview 14
5.1.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 14
5.2 Mayo Clinic Company Overview 17
5.2.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 17
5.3 Medtronic plc Company Overview 19
5.3.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 19
5.4 MicroPort CRM Company Overview 23
5.4.1 MicroPort CRM Pipeline Products & Ongoing Clinical Trials Overview 23
5.5 St. Jude Medical LLC Company Overview 28
5.5.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 28
5.6 Teleflex Inc Company Overview 32
5.6.1 Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview 32
6 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads- Recent Developments 33
6.1 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 33
6.2 Nov 18, 2019: Integer updates 2019 guidance following customer chapter 11 filing, no change in prior view of 2020 sales outlook 35
6.3 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 36
6.4 Nov 12, 2019: T2 Biosystems reports third quarter 2019 financial highlights and provides corporate update 37
6.5 Nov 12, 2019: MRI Interventions reports 62% increase in 2019 third quarter revenue 38
7 Appendix 98
7.1 Methodology 98
7.2 About GlobalData 101
7.3 Contact Us 101
7.4 Disclaimer 101

List of Tables
Table 1: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Stage of Development
Table 2: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Territory
Table 3: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Regulatory Path
Table 4: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Estimated Approval Date
Table 5: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Ongoing Clinical Trials
Table 6: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads Companies - Pipeline Products by Stage of Development
Table 7: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Stage of Development
Table 8: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 9: MRI-Safe Implantable Cardiac Rhythm Management Lead - Product Status
Table 10: MRI-Safe Implantable Cardiac Rhythm Management Lead - Product Description
Table 11: Next Generation ICD Lead - Product Status
Table 12: Next Generation ICD Lead - Product Description
Table 13: X4 SYSTEM + QUAD LEAD - Product Status
Table 14: X4 SYSTEM + QUAD LEAD - Product Description
Table 15: Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
Table 16: Epicardial Pacing/sensing Lead - Product Status
Table 17: Epicardial Pacing/sensing Lead - Product Description
Table 18: Pacemaker/ICD Lead - Product Status
Table 19: Pacemaker/ICD Lead - Product Description
Table 20: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Attain Stability Quad MRI SureScan - Product Status
Table 22: Attain Stability Quad MRI SureScan - Product Description
Table 23: Medtronic plc - Ongoing Clinical Trials Overview
Table 24: Attain Stability Quad MRI SureScan - Attain Stability Quad Clinical Study
Table 25: Attain Stability Quad MRI SureScan - Personalized CRT - Attain Stability Quad Post-Approval Study
Table 26: MicroPort CRM Pipeline Products & Ongoing Clinical Trials Overview
Table 27: BonaFire - Active Pacing Lead - Product Status
Table 28: BonaFire - Active Pacing Lead - Product Description
Table 29: BonaFire - Passive Pacing Lead - Product Status
Table 30: BonaFire - Passive Pacing Lead - Product Description
Table 31: Nano Lead System - Product Status
Table 32: Nano Lead System - Product Description
Table 33: SonR Tist Lead Positioning - Product Status
Table 34: SonR Tist Lead Positioning - Product Description
Table 35: SonRFix Lead - Product Status
Table 36: SonRFix Lead - Product Description
Table 37: Tachy Lead - Product Status
Table 38: Tachy Lead - Product Description
Table 39: TX Brady Lead - Product Status
Table 40: TX Brady Lead - Product Description
Table 41: St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 42: Quartet NXT - Double Blend Lead - Product Status
Table 43: Quartet NXT - Double Blend Lead - Product Description
Table 44: Quartet NXT - Large S-Curve Lead - Product Status
Table 45: Quartet NXT - Large S-Curve Lead - Product Description
Table 46: Quartet NXT - Small S-Curve Lead - Product Status
Table 47: Quartet NXT - Small S-Curve Lead - Product Description
Table 48: Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 49: Pacemaker Lead - Product Status
Table 50: Pacemaker Lead - Product Description
Table 51: Glossary

List of Figures
Figure 1: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Stage of Development
Figure 2: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Territory
Figure 3: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Regulatory Path
Figure 4: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Estimated Approval Date
Figure 5: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Ongoing Clinical Trials

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[心血管ペーシングおよび植込み型除細動器(ICD)リード:医療機器パイプライン分析]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆